PET imaging for evaluation of metastatic colorectal cancer of the liver

被引：19

作者：

Erturk, Sukru Mehmet

Ichikawa, Tomoaki

Fujii, Hirofumi

Yasuda, Seiei

Ros, Pablo R.

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Cambridge, MA 02138 USA

[2] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA

[3] Tokai Univ, Dept Surg, Hiratsuka, Kanagawa 25912, Japan

来源：

EUROPEAN JOURNAL OF RADIOLOGY | 2006年 / 58卷 / 02期

关键词：

colorectal metastases; liver; PET; PET-CT;

D O I：

10.1016/j.ejrad.2005.11.042

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Colorectal cancer is a major cause of cancer death in Western Europe and United States; the liver is the most common site for colorectal metastases. PET has an important role in the management of patients with colorectal liver metastases. It is an effective tool to detect hepatic metastases and to monitor the response to systemic and local therapy. The major impact of PET-CT over PET alone is the improvement in the certainty of lesion location. PET-CT has the unique advantage to combine functional and anatomic imaging in an integrated scanner; it allows a thoroughly evaluation of patients with colorectal liver metastases. (C) 2005 Elsevier Ireland Ltd. All rights reserved.

引用

页码：229 / 235

页数：7

共 55 条

[1] Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings [J].